5
Scheme 2. Synthesis of the 3,4-disubstututed quinolin-6-yloxyacetamide fungicide 3.
In conclusion, we have worked out a synthesis pathway to a whole range of so far unknown quinoline derivatives. All 3,4,6-
trisubstituted quinoline described in this article, except 6 and 7, are new and did not appear in the chemical literature so far. All of
these 15 novel heterobiyclic compounds bear functional groups which are well-suited for further transformations, e.g. carboxylic
acid or ester functions, halogen substituents, terminal alkynes and hydroxyl groups either introduced by the Gould-Jacobs ring
closure reaction or formed by the cleavable of ethers. One of these many possible manipulations led to the synthesis of 3,4-
disubstituted quinolin-6-yloxyacetamide fungicides such as 3, which could not be prepared via the Skraup-type approach used to
obtain its analogs 1 and 2 without any substituent in position 4.
Acknowledgements
The authors gratefully acknowledge the excellent synthetic contributions of Antonietta Crisante, Thomas Fischer and Nadja
Kirchmair.
Supplementary data
Supplementary data (experimental details and spectroscopic data for compounds 3, 5 - 22) associated with this article can be found
in the online version.
References and notes
1.
2.
3.
4.
5.
6.
7.
8.
The Chemistry of Heterocyclic Compounds, Volume 32: Quinolines, Jones G, Ed.; Wiley: New York 1991.
Madapa S, Tusi Z, Batra S. Curr. Org. Chem. 2008;12:1116-1183.
Afzal O, Kumar S., Haider MR, Ali MR, Kumar R, Jaggi M, Bawa S. Eur. J. Med. Chem. 2015;97:871-910.
Srivastava SK, Jha A, Agarwal SK, Mukherjee R, Burman AC. Anti-cancer Agents Med. Chem. 2007;7:685-709.
Keri RS, Patil SA. Biomed. Pharmacother. 2014;68:1161-1175.
Vandekerckhove, S.; D’hooghe, M. Bioorg. Med. Chem. 2015;23:5098-5119.
Mukherjee S, Pal M. Curr. Med. Chem. 2013;20:4386-4410.
Lamberth C, Murphy Kessabi F, Beaudegnies R, Quaranta L, Trah S, Berthon, G, Cederbaum F, Knauf-Beiter G, Grasso V, Bieri S, Corran A,
Thacker U. Bioorg. Med. Chem. 2014;22:3922-3930.
9.
Beaudegnies R, Quaranta L, Murphy Kessabi F, Lamberth C, Knauf-Beiter G, Fraser T. Bioorg. Med. Chem. 2016;24:444-452.
10. Murphy Kessabi F, Quaranta L, Beaudegnies R, Lamberth C. Synlett 2016;27:1375-1378.
11. Lamberth C, Murphy Kessabi F, Beaudegnies R, Quaranta L, Trah S, Berthon G, Cederbaum F, Vettiger T, Prasanna CS. Synlett 2014;25:858-
862.
12. Hudson A. In: Li J-J, ed. Name Reactions in Heterocyclic Chemistry. Hoboken: Wiley; 2005:488-494.
13. Marco-Contelles J, Perez-Mayoral E, Samadi A, do Carmo Carreiras M, Soriano E. Chem. Rev. 2009;109:2652-2671.
14. Hartz RA. In: Li J-J, ed. Name Reactions in Heterocyclic Chemistry II. Hoboken: Wiley; 2011:376-384.
15. Curran TT. In: Li J-J, ed. Name Reactions in Heterocyclic Chemistry. Hoboken: Wiley; 2005:390-397.
16. Kouznetsov VV. Tetrahedron 2009;65:2721-2750.
17. Sangshetti JN, Zambare AS, Gonjari I, Shinde DB. Mini-Rev. Org. Chem. 2014;11:225-250.
18. Curran TT. In: Li J-J, ed. Name Reactions in Heterocyclic Chemistry. Hoboken: Wiley; 2005:398-406.
19. Curran TT. In: Li J-J, ed. Name Reactions in Heterocyclic Chemistry. Hoboken: Wiley; 2005:423-436.
20. Chen H, Wang Y, Liu T. Zhongguo Yiyao Gongye Zazhi 2013;44:1086-1088.
21. Shang Q-Z. Jingxi Huagong Zhongjianti 2014;44:28-33.
22. Leslie R, Leeb E, Smith RB. J. Chem. Educ. 2012;89:144-146.
23. Medapi B, Suryadevara P, Renuka J, Sridevi JP, Yogeeswari P, Sriram D. Eur. J. Med. Chem. 2015;103:1-16.
24. Goncalves V, Brannigan JA, Whalley D, Ansell KH, Saxty B, Holder AA, Wilkinson AJ, Tate EW, Leatherbarrow RJ. J. Med. Chem.
2012;55:3578-3582.
25. Hanna-Elias A, Manallack DT, Berque-Bestel I, Irving HR, Coupar IM, Iskander MN. Aust. J. Chem. 2009;62:150-156.